Leptin, the Ob gene product, has emerged recently as a key regulator of bone mass. However, the mechanism mediating leptin effect remains controversial. Because the action of leptin is dependent on its receptors, we analyzed their expression in osteoblast-lineage primary human bone marrow stromal cells (hBMSC). Both the short and long forms of leptin receptors were detected in hBMSC. Leptin significantly decreased the viability of hBMSC. This cytotoxic effect was prevented by ZVal-Ala-Asp-fluoromethylketone, a pan-caspase inhibitor, implicating that leptin-induced hBMSC death was caspase-dependent. Further investigation demonstrated that leptin activated caspase-3 and caspase-9, but not caspase-8, and increased the cleavage of poly-(ADP-ribose) polymerase and cytochrome c release into cytosol. Leptin activated ERK, but not p38 and JNK, and up-regulated cPLA2 activity; the latter was abolished by pre-treatment of cells with the MEK inhibitor (PD98059 or U0126) or cPLA2 inhibitor (AACOCF3). PD98059, U0126, and AACOCF3 also diminished the leptin-induced cytochrome c release into cytosol, cell death, and caspase-3 activation. These data indicated that leptin induced hBMSC apoptosis via ERK/cPLA2/cytochrome c pathway with activation of caspase-9 and caspase-3, and cleavage of poly(ADP-ribose) polymerase. To our knowledge, this is the first study demonstrating the direct detrimental effect of leptin on bone cells.Leptin, the protein product encoded by obese gene, is a circulating hormone produced primarily by the adipose tissue and is a multifunctional hormone that plays important roles in body weight homeostasis, neuroendocrine function, fertility, immune function, and angiogenesis (1-3). The biological actions of leptin on target tissues are carried out through interaction with its specific receptor, Ob-R (4). A hallmark of Ob-R expression is the presence of several receptor variants (Ob-Ra through Ob-Rf) that are generated by alternative splicing; they share the same extracellular domain but differ in the length of the transmembrane/cytoplasmic coding regions (2). The long Ob-Rb subtype (Ob-R L ) appears as the functional, signal-transducing isoform, responsible for the action of leptin. The roles of the shorter Ob-R isoforms (Ob-R S ) remain to be characterized. Although leptin's precise sites of action are not known, its effect is thought largely mediated via hypothalamus. However, the wide expression of Ob-R L throughout the body suggests that leptin may also operate directly in peripheral tissues (5). There is now a significant amount of evidence implicating that leptin is active in the periphery (6).Recently, leptin has emerged as a key element in the regulation of bone mass. However, the mechanism by which leptin acts upon the bone remains unclear. Thomas et al. (7) reported that leptin enhanced the differentiation of hBMSC, 1 and Steppan et al. (8) reported that the femurs of leptindeficient ob/ob mice were shorter than those in the normal mice, and intraperitoneal injection of leptin significantly increas...